Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

NCT02796170 is registered in ClinicalTrials.gov with Tulane University School of Medicine as lead sponsor.

NCT NCT02796170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02796170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
Lead sponsor
Tulane University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
August 31, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type 2 diabetes